Skip to main content



Local Cdiff information for Pennsylvania

Pennsylvania

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Pennsylvania.



Local Cdiff information for Pennsylvania

Pennsylvania

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Pennsylvania.

Providers

Dr. Lindsey Surace, MD

Jackson Siegelbaum Gastroenterology
423 N 21st Street
Camp Hill, 17011
(717) 761-0930
FMT Provider: No
VISIT WEBSITE >

Dr. Paul G. Lacey, MD, FACP, FACG

Jackson Siegelbaum Gastroenterology
423 N 21st Street
Camp Hill, 17011
(717) 761-0930
FMT Provider: No
VISIT WEBSITE >

Dr. Sam Banerjee, MD

Jackson Siegelbaum Gastroenterology
423 N 21st Street
Camp Hill, 17011
(717) 761-0930
FMT Provider: No
VISIT WEBSITE >

Dr. John J. Michel, DO

Jackson Siegelbaum Gastroenterology
423 N 21st Street
Camp Hill, 17011
(717) 761-0930
FMT Provider: No
VISIT WEBSITE >

Dr. Adnan Ahmad, DO

Jackson Siegelbaum Gastroenterology
423 N 21st Street
Camp Hill, 17011
(717) 761-0930
FMT Provider: No
VISIT WEBSITE >

Dr. Wilson Jackson, MD, FACP, FACG, AGAF

Jackson Siegelbaum Gastroenterology
4387 Sturbridge Drive
Harrisburg, 17110
(717) 238-3111
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 4053
Hospital Onset: 4053
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.79
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: Yes
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: Yes
Law/Regulation: Not available
STATUTE >

State Contact

Ram Nambiar, MD, MPH
Acting, Director
Pennsylvania Department of Health
Division of Infectious Disease Epidemiology, Health & Welfare Building
625 Forster Street
Harrisburg, 17120
(717) 787.3350
(717) 772.6975
EMAIL RAM NAMBIAR, MD, MPH >

CLINICAL TRIALS

REMBRANDT

Official Title: Impact of Pet Contact on Antimicrobial-associated Dysbiosis and Clostridioides Difficile Infection
Trial No. NCT05622721
Type: Observational
Recruitment: Recruiting
Sponsor: University of Pennsylvania
Contact: Laurel Redding, VMD, PhD
610-925-6307
EMAIL
Gender: All
Age: 50 Years and older

Animal-Assisted Visitation Program Chlorhexidine Trial

Official Title: Clinical Trial of a Disinfectant Intervention in Therapy Dogs to Combat Hospital-associated Pathogens and Promote Sustainability of Animal-Assisted Visitation Programs
Trial No. NCT04171817
Type: Interventional
Recruitment: Recruiting
Sponsor: Johns Hopkins Bloomberg School of Public Health
Contact: Meghan F Davis, DVM PhD
410-614-8283
EMAIL
Gender: All
Age: 3 Years to 17 Years

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
EMAIL
Gender: All
Age: 18 Years and older

FMT in Pediatric C. difficile

Official Title: Fecal Microbiome Transplant in Pediatric C. Difficile
Trial No. NCT02636517
Type: Interventional
Recruitment: Recruiting
Sponsor: Judith Kelsen, MD
Contact: Judith Kelsen, MD
267-426-6822
EMAIL
Gender: All
Age: 2 Years to 21 Years

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.